Omthera Pharmaceuticals has reported positive data showing that its prescription-grade omega-3 fatty acid candidate, Epanova, has better bioavailability than Lovaza...
Teva Pharmaceutical Industries Ltd. has announced the approval on 8 April 2014 of the generic equivalent to Lovaza (Omega-3-Acid Ethyl...